Selected research
Market Outlook & Growth Opportunities
Global Functional Brain Imaging Market Outlook and Growth Opportunities 2026
Market perspective
The global Functional Brain Imaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Functional Brain Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Functional Brain Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Functional Brain Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Functional Brain Imaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Functional Brain Imaging market include EB Neuro, MinFound Medical Systems, Neurosoft, Medtronic, Nihon Kohden, Hitachi Medical Systems, Elekta, Philips and General Electric, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Functional Brain Imaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Functional Brain Imaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Functional Brain Imaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Functional Brain Imaging market.
Functional Brain Imaging Segment by Company
EB Neuro
MinFound Medical Systems
Neurosoft
Medtronic
Nihon Kohden
Hitachi Medical Systems
Elekta
Philips
General Electric
Canon Medical Systems
Functional Brain Imaging Segment by Type
Functional MR Imaging (fMRI) Systems
Functional Near Infrared Spectroscopy (fNIRS) Systems
Positron Emission Tomography (PET) System
Others
Functional Brain Imaging Segment by Application
Hospital
Diagnostic Imaging Center
Others
Functional Brain Imaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Functional Brain Imaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Functional Brain Imaging key companies, revenue, market share, and recent developments.
3. To split the Functional Brain Imaging breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Functional Brain Imaging market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Functional Brain Imaging significant trends, drivers, influence factors in global and regions.
6. To analyze Functional Brain Imaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Brain Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Functional Brain Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Brain Imaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Functional Brain Imaging industry.
Chapter 3: Detailed analysis of Functional Brain Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Functional Brain Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Functional Brain Imaging in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Functional MR Imaging (fMRI) Systems
- Functional Near Infrared Spectroscopy (fNIRS) Systems
- Positron Emission Tomography (PET) System
- Others
Applications
- Hospital
- Diagnostic Imaging Center
- Others
Companies covered
- EB Neuro
- MinFound Medical Systems
- Neurosoft
- Medtronic
- Nihon Kohden
- Hitachi Medical Systems
- Elekta
- Philips
- General Electric
- Canon Medical Systems
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Functional Brain Imaging Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Functional Brain Imaging Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Functional Brain Imaging Market Dynamics
- 2.1 Functional Brain Imaging Industry Trends
- 2.2 Functional Brain Imaging Industry Drivers
- 2.3 Functional Brain Imaging Industry Opportunities and Challenges
- 2.4 Functional Brain Imaging Industry Restraints
3 Functional Brain Imaging Market by Company
- 3.1 Global Functional Brain Imaging Company Revenue Ranking in 2025
- 3.2 Global Functional Brain Imaging Revenue by Company (2021-2026)
- 3.3 Global Functional Brain Imaging Company Ranking (2024-2026)
- 3.4 Global Functional Brain Imaging Company Manufacturing Base and Headquarters
- 3.5 Global Functional Brain Imaging Company Product Type and Application
- 3.6 Global Functional Brain Imaging Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Functional Brain Imaging Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Functional Brain Imaging Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Functional Brain Imaging Market by Type
- 4.1 Functional Brain Imaging Type Introduction
- 4.1.1 Functional MR Imaging (fMRI) Systems
- 4.1.2 Functional Near Infrared Spectroscopy (fNIRS) Systems
- 4.1.3 Positron Emission Tomography (PET) System
- 4.1.4 Others
- 4.2 Global Functional Brain Imaging Sales Value by Type
- 4.2.1 Global Functional Brain Imaging Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Functional Brain Imaging Sales Value by Type (2021-2032)
- 4.2.3 Global Functional Brain Imaging Sales Value Share by Type (2021-2032)
5 Functional Brain Imaging Market by Application
- 5.1 Functional Brain Imaging Application Introduction
- 5.1.1 Hospital
- 5.1.2 Diagnostic Imaging Center
- 5.1.3 Others
- 5.2 Global Functional Brain Imaging Sales Value by Application
- 5.2.1 Global Functional Brain Imaging Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Functional Brain Imaging Sales Value by Application (2021-2032)
- 5.2.3 Global Functional Brain Imaging Sales Value Share by Application (2021-2032)
6 Functional Brain Imaging Regional Value Analysis
- 6.1 Global Functional Brain Imaging Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Functional Brain Imaging Sales Value by Region (2021-2032)
- 6.2.1 Global Functional Brain Imaging Sales Value by Region: 2021-2026
- 6.2.2 Global Functional Brain Imaging Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Functional Brain Imaging Sales Value (2021-2032)
- 6.3.2 North America Functional Brain Imaging Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Functional Brain Imaging Sales Value (2021-2032)
- 6.4.2 Europe Functional Brain Imaging Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Functional Brain Imaging Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Functional Brain Imaging Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Functional Brain Imaging Sales Value (2021-2032)
- 6.6.2 South America Functional Brain Imaging Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Functional Brain Imaging Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Functional Brain Imaging Sales Value Share by Country, 2025 VS 2032
7 Functional Brain Imaging Country-level Value Analysis
- 7.1 Global Functional Brain Imaging Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Functional Brain Imaging Sales Value by Country (2021-2032)
- 7.2.1 Global Functional Brain Imaging Sales Value by Country (2021-2026)
- 7.2.2 Global Functional Brain Imaging Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.7.2 France Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.14.2 China Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.17.2 India Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Functional Brain Imaging Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Functional Brain Imaging Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Functional Brain Imaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 EB Neuro
- 8.1.1 EB Neuro Company Information
- 8.1.2 EB Neuro Business Overview
- 8.1.3 EB Neuro Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.1.4 EB Neuro Functional Brain Imaging Product Portfolio
- 8.1.5 EB Neuro Recent Developments
- 8.2 MinFound Medical Systems
- 8.2.1 MinFound Medical Systems Company Information
- 8.2.2 MinFound Medical Systems Business Overview
- 8.2.3 MinFound Medical Systems Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.2.4 MinFound Medical Systems Functional Brain Imaging Product Portfolio
- 8.2.5 MinFound Medical Systems Recent Developments
- 8.3 Neurosoft
- 8.3.1 Neurosoft Company Information
- 8.3.2 Neurosoft Business Overview
- 8.3.3 Neurosoft Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.3.4 Neurosoft Functional Brain Imaging Product Portfolio
- 8.3.5 Neurosoft Recent Developments
- 8.4 Medtronic
- 8.4.1 Medtronic Company Information
- 8.4.2 Medtronic Business Overview
- 8.4.3 Medtronic Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.4.4 Medtronic Functional Brain Imaging Product Portfolio
- 8.4.5 Medtronic Recent Developments
- 8.5 Nihon Kohden
- 8.5.1 Nihon Kohden Company Information
- 8.5.2 Nihon Kohden Business Overview
- 8.5.3 Nihon Kohden Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.5.4 Nihon Kohden Functional Brain Imaging Product Portfolio
- 8.5.5 Nihon Kohden Recent Developments
- 8.6 Hitachi Medical Systems
- 8.6.1 Hitachi Medical Systems Company Information
- 8.6.2 Hitachi Medical Systems Business Overview
- 8.6.3 Hitachi Medical Systems Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.6.4 Hitachi Medical Systems Functional Brain Imaging Product Portfolio
- 8.6.5 Hitachi Medical Systems Recent Developments
- 8.7 Elekta
- 8.7.1 Elekta Company Information
- 8.7.2 Elekta Business Overview
- 8.7.3 Elekta Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.7.4 Elekta Functional Brain Imaging Product Portfolio
- 8.7.5 Elekta Recent Developments
- 8.8 Philips
- 8.8.1 Philips Company Information
- 8.8.2 Philips Business Overview
- 8.8.3 Philips Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.8.4 Philips Functional Brain Imaging Product Portfolio
- 8.8.5 Philips Recent Developments
- 8.9 General Electric
- 8.9.1 General Electric Company Information
- 8.9.2 General Electric Business Overview
- 8.9.3 General Electric Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.9.4 General Electric Functional Brain Imaging Product Portfolio
- 8.9.5 General Electric Recent Developments
- 8.10 Canon Medical Systems
- 8.10.1 Canon Medical Systems Company Information
- 8.10.2 Canon Medical Systems Business Overview
- 8.10.3 Canon Medical Systems Functional Brain Imaging Revenue and Gross Margin (2021-2026)
- 8.10.4 Canon Medical Systems Functional Brain Imaging Product Portfolio
- 8.10.5 Canon Medical Systems Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst